Project/Area Number |
24791088
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Pediatrics
|
Research Institution | Keio University |
Principal Investigator |
SUWANAI Ayuko 慶應義塾大学, 医学部, 共同研究員 (90383851)
|
Research Collaborator |
HASEGAWA Tomonobu 慶應義塾大学, 医学部, 教授 (20189533)
NARUMI Satoshi 慶應義塾大学, 医学部, 特任助教 (40365317)
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 先天性甲状腺機能低下症 / 遺伝 / リスク因子 / 小児 / 遺伝子 / 罹患率 / 甲状腺 |
Research Abstract |
The etiology of congenital hypothyroidism (CH) is largely unknown. A minor subset of CH patients has single gene mutation. However, it has not been studied whether simultaneous mutations in two or more genes can cause CH. In the present study, we enrolled and sequenced 401 CH patients, and found 4 patients that had heterozygous mutations in the TSH receptor gene (TSHR) and the dual oxidase 2 gene (DUOX2) simultaneously ("double heterozygotes"). Based on the frequencies of heterozygotes of TSHR (1/172) and DUOX2 (1/67), such double heterozygotes are expected to be observed in 1/11,524 in the general population. Thus, considering the frequency of CH (1/3,000) and the frequency of double heterozygotes among CH patients (4/401), most double heterozygotes are not affected by CH. Nonetheless, extremely high rate of double heterozygotes among CH patients, as compared with among the general population, indicates that simultaneous mutations in TSHR and DUOX2 acts as a strong risk factor for CH.
|